You are here > Home

Welcome to SAFENANO 

SAFENANO is Europe's Centre of Excellence on Nanotechnology Hazard and Risk, based at the Institute of Occupational Medicine (IOM). 

SAFENANO facilitates responsible development of safe nanomaterials and nanotechnology-enabled products by making use of an integrated approach which gives users access to:
SAFENANO's Key features

SAFENANO Knowledge Base
 - focused on interpreting and disseminating emerging scientific evidence about the potential risks to health and the environment arising from the development and use of nanotechnology.

SAFENANO Scientific Services - brings together multidisciplinary expertise in hazard assessment, exposure, toxicology, occupational hygiene and risk assessment to provide independent, authoritative consultancy on risk and safety.

 - brings together our team’s multidisciplinary expertise in collaborative work with industry and other organisations in order to help identify and address any likely health hazards and risks from nanotechnologies.

Recent News Articles
EC and SCENIHR begin Public Consultation on the determination of potential health effects of nanomaterials used in medical devices

EC and SCENIHR begin public consultation on preliminary opinion on guidance on the determination of potential health effects of nanomaterials used in medical devices

EC issues Draft Reports for Impact Assessment on Transparency Measures for Nanomaterials

The European Commission have released three reports following a validation workshop to discuss the preliminary results of the study supporting the impact assessment on transparency measures for nanom...

NNI releases progress review on environmental, health, & safety research

The National Nanotechnology Initiative (NNI) has released a Progress Review on the Coordinated Implementation of the NNI 2011 Environmental, Health, and Safety Research Strategy.

FDA issues guidance to support the responsible development of nanotechnology products

The U.S Food and Drug Administration has issued guidances on the use of nanotechnology in FDA-regulated products.

European Commission publishes final opinion on nanosilver

EC publishes final opinion on "Nanosilver: safety, health and environmental effects and role in antimicrobial resistance".

Researchers investigate biodistribution of carbon nanotubes in vivo

CEA and CNRS researchers investigate tissue biodistribution of radiolabelled multi-walled carbon nanotubes in mice over 12 months.

European industry associations call for balanced policy on nanomaterials

Fifteen industry associations have together endorsed a recently published leaflet entitled “Europe needs safe and innovative nanotechnologies and nanomaterials”.

German Environment Agency assesses carcinogenicity and mutagenicity of nanoparticles

The German Federal Environment Agency has published a review of existing knowledge on the carcinogenicity and mutagenicity of nanoparticles.

OECD report highlights policy issues related to nanotechnology use in the tyre industry

The Organisation for Economic Co-operation and Development (OECD) has published a new report providing important insights into the policy issues related to nanotechnology use in the tyre industry.

OECD publishes Report of Expert Meeting on Physico-chemical Properties of Manufactured Nanomaterials and Test Guidelines

The Organization for Economic Cooperation and Development (OECD) has published a Report of the Expert Meeting on the Physical Chemical Properties of Manufactured Nanomaterials and Test Guidelines.

Upcoming Events
As a side event of the XX World Congress on Safety and Health at work, the ISSA (International Social Security Association) are holding a course entitled 'Assessment and management of exposure to chemical agents and nanomaterals; The role of Occupational Exposure Limits' on the ...